Friend or foe: the role of microRNA in chemotherapy resistance
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.nature.com/articles/aps201335.pdf
Reference112 articles.
1. Gong J, Jaiswal R, Mathys JM, Combes V, Grau GE, Bebawy M . Microparticles and their emerging role in cancer multidrug resistance. Cancer Treat Rev 2012; 38: 226–34.
2. Viticchie G, Lena AM, Latina A, Formosa A, Gregersen LH, Lund AH, et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011; 10: 1121–31.
3. Shatseva T, Lee DY, Deng Z, Yang BB . MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci 2011; 124: 2826–36.
4. Yu B, Zhou S, Wang Y, Qian T, Ding G, Ding F, et al. miR-221 and miR-222 promote Schwann cell proliferation and migration by targeting LASS2 after sciatic nerve injury. J Cell Sci 2012; 125: 2675–83.
5. Pernaute B, Spruce T, Rodriguez TA, Manzanares M . MiRNA-mediated regulation of cell signaling and homeostasis in the early mouse embryo. Cell Cycle 2011; 10: 584–91.
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MiRNAs as Promising Therapeutic Targets for Breast Cancer;OBM Genetics;2024-02-26
2. Transfection of Unmodified MicroRNA Using Monolayer-Coated Au Nanoparticles as Gene-Delivery Vehicles;ACS Applied Bio Materials;2023-12-22
3. A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer;Pathology - Research and Practice;2023-11
4. Ugonin P inhibits lung cancer motility by suppressing DPP-4 expression via promoting the synthesis of miR-130b-5p;Biomedicine & Pharmacotherapy;2023-11
5. Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy;Journal of Nanobiotechnology;2023-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3